Disease & disorder

myasthenic syndrome, congenital, 1B, fast-channel

MONDO:0012156

A congenital myasthenic syndrome characterized by defects in postsynaptic neuromuscular junctions with early-onset progressive muscle weakness that has material basis in mutation in the CHRNA1 gene on chromosome 2q.

Outbreak surveillance

Global reported events

Explore recent public health notices potentially related to myasthenic syndrome, congenital, 1B, fast-channel. Results are keyword matches, not yet verified disease-to-outbreak relationships.

View myasthenic syndrome, congenital, 1B, fast-channel on the outbreak map →
Clinical trials0
Recruiting0
Drug concepts studied0
Synonyms3
Advertisement
Background context

myasthenic syndrome, congenital, 1B, fast-channel

Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.

Drugs being studied

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.